Home LiteratureArticle Details
PMID: 19622825 Published · ppublish English Comment Editorial Research Support, N.I.H., Extramural

Use of Alzheimer disease biomarkers: potentially yes for clinical trials but not yet for clinical practice.

JAMA ·Vol. 302 ·No. 4 ·2009-07-22 ·Pages 436-7

Petersen RC, Trojanowski JQ

Abstract

暂无摘要

MeSH Terms
Alzheimer Disease/cerebrospinal fluid,diagnosis Amyloid beta-Peptides/cerebrospinal fluid Biomarkers/cerebrospinal fluid Clinical Trials as Topic Humans Patient Care Peptide Fragments/cerebrospinal fluid Predictive Value of Tests tau Proteins/cerebrospinal fluid
Chemicals
Amyloid beta-Peptides Biomarkers Peptide Fragments amyloid beta-protein (1-42) tau Proteins
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Petersen Ronald C
Trojanowski John Q
References (9)
9 references, click to expand
  1. Vitamin E and donepezil for the treatment of mild cognitive impairment.
    N Engl J Med. 2005 Jun 9;352(23):2379-88 PMID: 15829527
  2. Mild cognitive impairment.
    Lancet. 2006 Apr 15;367(9518):1262-70 PMID: 16631882
  3. Mild cognitive impairment as a diagnostic entity.
    J Intern Med. 2004 Sep;256(3):183-94 PMID: 15324362
  4. Mild cognitive impairment: clinical characterization and outcome.
    Arch Neurol. 1999 Mar;56(3):303-8 PMID: 10190820
  5. Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects.
    Ann Neurol. 2009 Apr;65(4):403-13 PMID: 19296504
  6. CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment.
    JAMA. 2009 Jul 22;302(4):385-93 PMID: 19622817
  7. Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease.
    Brain. 2009 May;132(Pt 5):1355-65 PMID: 19339253
  8. Current concepts in mild cognitive impairment.
    Arch Neurol. 2001 Dec;58(12):1985-92 PMID: 11735772
  9. Mild cognitive impairment--beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment.
    J Intern Med. 2004 Sep;256(3):240-6 PMID: 15324367
Article Info
Journal
JAMA
Abbr.
JAMA
ISSN
1538-3598
DOI
10.1001/jama.2009.1073
Published
2009-07-22
Pages
436-7
Language
English
Region
United States
NLM ID
7501160
PMCID
PMC2792581
Subset
IM
Grants
NIA NIH HHS · U01 AG024904-01 · United States
NIA NIH HHS · U01 AG024904-04 · United States
NIA NIH HHS · U01 AG24904 · United States
NIA NIH HHS · U01 AG024904 · United States
NIA NIH HHS · U19 AG010483 · United States
Corrections
CommentOn
PMID: 19622817
External Links
PubMed source DOI: 10.1001/jama.2009.1073 PMC Full Text View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2